Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Lasofoxifene versus fulvestrant for ER+/HER2− metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial
Matthew Philip Goetz, Nusayba Ali Bagegni, Gerald Batist, Adam Brufsky, Massimo Cristofanilli, Senthil Damodaran and 21 more
- Rank
- 59 of 3,639
- Percentile
- top 1.7%
- Where
- Annals of Oncology, 2023
- Citations
- 62
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.